首页|铁死亡在阿霉素心肌病中的作用机制

铁死亡在阿霉素心肌病中的作用机制

Mechanisms of Ferroptosis in Doxorubicin-Induced Cardiomyopathy

扫码查看
阿霉素是目前应用最广泛的抗肿瘤药,但其心脏毒性限制了临床疗效.阿霉素可引起心肌细胞损伤、心脏进行性扩大和不可逆的心肌损伤,最终导致扩张型心肌病及充血性心力衰竭,称为阿霉素心肌病(DIC).DIC的发病机制包括钙处理异常、氧化应激、线粒体破坏、凋亡和自噬等.近期多项研究报道了一种新的调节性细胞死亡——铁死亡参与其发病.现描述铁死亡的主要机制,并总结铁超载、PRMT4、Sirt1/Nrf2/Keap1通路、FUNDC2、METTL14介导的铁死亡在DIC中的作用机制,旨在对DIC病理生理机制有进一步的认识,为DIC治疗及预防提供新的潜在有效靶点.
Doxorubicin(DOX)is the most widely used antitumor drug,but its cardiotoxicity limits clinical efficacy.DOX can cause cardiomyocyte loss,progressive cardiac enlargement,and irreversible myocardial injury,ultimately leading to dilated cardiomyopathy and congestive heart failure,called DOX-induced cardiomyopathy(DIC).Several recent studies have reported the involvement of a new type of regulated cell death,ferroptosis,in its pathogenesis.This review describes the major mechanisms of ferroptosis and summarize the mechanisms of iron overload,PRMT4,Sirt1/Nrf2/Keap1 pathway,FUNDC2,and METTL14 mediated ferroptosis in DIC,aiming to gain further insights into the pathophysiological mechanisms of DIC,and to provide a new and potentially effective target for DIC treatment and prevention.

FerroptosisDoxorubicin-induced cardiomyopathyMechanism

宋自崇、王静艺、张黎军

展开 >

武汉大学人民医院老年病科,湖北武汉 430060

华中科技大学同济医学院附属同济医院神经内科,湖北武汉 430030

铁死亡 阿霉素心肌病 机制

2024

心血管病学进展
成都市心血管病研究所,成都市第三人民医院

心血管病学进展

CSTPCD
影响因子:0.932
ISSN:1004-3934
年,卷(期):2024.45(4)